AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

Clinical trial NCT07038343 · RECRUITING

Trial details

NCT number: NCT07038343
Sponsor: Avenzo Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumor Cancer Locally Advanced Metastatic Solid Tumors Lung Cancers Epithelial Tumor Biliary Tract Cancer (BTC)Urothelial Cancer Nasopharyngeal Cancers

Start date: 2025-06-04
Primary completion: 2030-06-01
Enrollment: 480

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.